<DOC>
	<DOCNO>NCT01971385</DOCNO>
	<brief_summary>Subjects history recurrent herpes labialis sensitize either 2 % SADBE placebo . Following , subject sensitize 2 % SADBE received.2 % sqauric acid or.5 % squaric acid cold sore within 72 hour recurrence . Subjects sensitize placebo solution receive placebo solution cold sore within 72 hour recurrence . Subjects follow 6 mo application study medication .</brief_summary>
	<brief_title>Safety Efficacy Squaric Acid Dibutyl Ester Treatment Herpes Labialis</brief_title>
	<detailed_description />
	<mesh_term>Herpes Labialis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Dimethyl Sulfoxide</mesh_term>
	<mesh_term>Squaric acid dibutyl ester</mesh_term>
	<criteria>Age &gt; 18 With clinical diagnosis herpes labialis . self report six episodes herpes labialis previous 12 month . Pregnant lactating female . Current recurrent infection underlie condition may predispose infection anyone admit hospital due bacteremia , pneumonia serious infection . Therapy glucocorticoid immunosuppressant time recruitment within past 4 week , except inhaled corticosteroid asthma . History malignancy ( except patient surgically cure basal cell squamous cell skin cancer eligible ) History organ transplantation Negative HIVpositive status determine history screen know history immunosuppressing disease . Severe comorbidities ( diabetes mellitus require insulin , CHF ( EF &lt; 50 % baseline exclusionary ) severity , MI , CVA TIA within 3 month screen visit , unstable angina pectoris , oxygendependent severe pulmonary disease Subject currently enrol another investigational device drug trial ( ) , subject receive investigational agent ( ) within 28 day baseline visit . Subjects know hypersensitivity Squaric acid component . History recent alcohol substance abuse ( &lt; 1 year ) Any condition judge investigator cause clinical trial detrimental patient . History psychiatric disease would interfere patient 's ability comply study protocol History noncompliance therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>